Cara Care has been acquired by Mahana Therapeutics
February 2024 — Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.
Cara Care is the leading German digestive health therapeutic solution that combines both, mental and nutritional therapy options. With its MDR Class I approved IBS solution which is fully reimbursed by all German SHI and DiGA-certified providers, the company stands as a pioneer and demonstrates growth in an underserved sector. Venture capital-backed with lead investors Atlantic Labs, Asabys Partners, Johnson & Johnson Innovation & Dr. Schar, Cara Care was able to build a product pipeline not only for IBS but also heartburn, dyspepsia and IBD.
Mahana Therapeutics is a US-based company that stands at the forefront of digital health innovation, specializing in the development of digital therapeutics for chronic health conditions. With a focus on cognitive and behavioral therapy-based solutions, Mahana has secured FDA clearance for its pioneering IBS treatment program Mahana IBS, demonstrating its commitment to clinically validated and regulatory-compliant healthcare interventions. Backed by significant venture capital and strategic partnerships, Mahana Therapeutics is expanding its treatment portfolio to address a wider range of chronic conditions, leveraging technology to improve patient outcomes and accessibility to care.
Our role in the transaction
Oaklins’ team in Germany provided comprehensive advisory services to the private shareholder of Cara Care in this transaction.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn more360 Experience Group has merged with GoodFellows
360 Experience Group, a European end-to-end service provider of live experiences, and GoodFellows have merged to create one of the largest live experiences players in Europe. By pooling their strengths under the 360 Experience Group banner, the merged group will span the full breadth of the live industry and bring together 16 specialized companies, including Live Legends, Unlimited Productions, Unbranded, TIG Sports and Events and Kumpany. The group will provide end-to-end solutions for the realization of large-scale live entertainment, international sports and public events and impactful brand activations. The combined business will generate over US$90 million in revenue and employ more than 230 people.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn more